Gufic Biosciences Limited

NSE GUFICBIO.NS

Gufic Biosciences Limited Dividends Paid for the year ending March 31, 2024: USD -116.53 K

Gufic Biosciences Limited Dividends Paid is USD -116.53 K for the year ending March 31, 2024, a 8.23% change year over year. Dividends paid is cash paid to shareholders as a distribution of profits.

Gufic Biosciences Limited Dividends Paid for the year ending March 31, 2023 was USD -126.99 K, a -4.68% change year over year.
Gufic Biosciences Limited Dividends Paid for the year ending March 31, 2022 was USD -121.31 K, a -144.77% change year over year.
Gufic Biosciences Limited Dividends Paid for the year ending March 31, 2021 was USD -49.56 K, a 23.39% change year over year.
Gufic Biosciences Limited Dividends Paid for the year ending March 31, 2020 was USD -64.69 K, a -16.01% change year over year.

Key data

Date	Dividends Paid	Capital Expenditure	Other Financing Activities	Net Cash Used Provided By Financing Activities

NSE: GUFICBIO.NS

Gufic Biosciences Limited

CEO	Mr. Pranav Jayesh Choksi
IPO Date	Oct. 19, 2004
Location	India
Headquarters	SM House
Employees	1,491
Sector	Health Care
Industries Pharmaceuticals

Description

Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to more than 20 countries. The company was founded in 1970 and is based in Mumbai, India.

Key trends

Past 5 years